Senores Pharmaceuticals Limited (BOM:544319)
1,514.65
-0.40 (-0.03%)
At close: Aug 21, 2026
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 69.69 billion as of August 21, 2026. Its market cap has increased by 112.59% in one year.
Market Cap
69.69B
Enterprise Value
71.83B
Revenue
6.80B
Ranking
n/a
PE Ratio
54.72
Stock Price
1,514.65
ChartMarket Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 69.69B, an increase of 171.66%. That is a compound annual growth rate of 83.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 69.69B | 84.05% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 139.25B |
| CORONA Remedies | 131.04B |
| Viyash Scientific | 120.57B |
| Procter & Gamble Health | 96.85B |
| Sanofi India | 77.11B |
| Bliss GVS Pharma | 61.86B |
| FDC Limited | 56.69B |
| Morepen Laboratories | 52.60B |